Drugs for Peptic Ulcer Disease (PUD)

📋 Abbreviations & Key Terms

Essential medical shorthand and terminology explained:

Abbreviation	Full Term	Explanation
PUD	Peptic Ulcer Disease	Ulcers (sores) in the stomach or duodenum caused by acid/pepsin damage
PPI	Proton Pump Inhibitor	Drugs that block the final step of acid production (most potent acid reducers)
H₂RA	Histamine H₂-Receptor Antagonist	Drugs that block histamine-stimulated acid secretion (less potent than PPIs)
GERD	Gastroesophageal Reflux Disease	Chronic acid reflux that can cause heartburn and damage the esophagus
H. pylori	Helicobacter pylori	A spiral-shaped bacterium that infects the stomach lining and causes ulcers
NSAID	Non-Steroidal Anti-Inflammatory Drug	Pain relievers (like ibuprofen) that can damage the stomach lining
H⁺/K⁺ ATPase	Proton-Potassium Adenosine Triphosphatase	The "proton pump" - the final enzyme that secretes acid into the stomach
CYP450	Cytochrome P450	A family of liver enzymes that metabolize (break down) many drugs
MALT	Mucosa-Associated Lymphoid Tissue	Lymphoid tissue in the stomach; H. pylori can cause MALT lymphoma
PGE₁	Prostaglandin E₁	A natural compound that protects the stomach lining; mimicked by misoprostol

⚖️ The Acid Balance: Aggressive vs. Defensive Factors

Peptic ulcers develop when the balance tips in favor of aggressive factors. Think of this as a scale: on one side are factors that damage the stomach lining, on the other are factors that protect it. Ulcers form when the damage side becomes too heavy:

⚔️ Aggressive Factors (The Attackers)

Gastric Acid (HCl): The primary corrosive agent; necessary for digestion but damaging in excess
Pepsin: A protein-digesting enzyme activated by acid; eats away at stomach lining
H. pylori Infection: Bacteria that weaken the mucus barrier and cause inflammation
NSAIDs: Block protective prostaglandins, reduce mucus and bicarbonate production
Smoking & Alcohol: Reduce blood flow to stomach lining, impair healing
Stress: Increases acid production, reduces blood flow (especially in critically ill patients)
Key Concept: These factors create the "offense" that breaks through stomach defenses

🛡️ Defensive Factors (The Protectors)

Mucus-Bicarbonate Barrier: Thick mucus layer with alkaline bicarbonate neutralizes acid
Mucosal Blood Flow: Delivers oxygen and nutrients, removes acid and toxins
Prostaglandins: Hormone-like substances that increase mucus, bicarbonate, and blood flow
Epithelial Cell Renewal: Rapid turnover of stomach lining cells (every 3-5 days)
Growth Factors: Stimulate healing and maintain mucosal integrity
Key Concept: These factors form the "defense system" that normally prevents ulcer formation

🎯 Clinical Memory Aid: Remember the "Two Main Causes of PUD":

H. pylori infection (causes ~70% of ulcers) - "Bug"
NSAID use (causes ~25% of ulcers) - "Drug"
Other: Stress ulcers, Zollinger-Ellison syndrome, smoking (remainder)

Treatment differs based on cause: H. pylori ulcers need antibiotics, NSAID ulcers need protection and stopping the drug.

💊 Drug Classes: Strategic Approach

PUD treatment uses a multi-pronged approach: reduce acid production (PPIs, H₂ blockers), protect the lining (mucosal protectants), neutralize existing acid (antacids), and eliminate H. pylori (antibiotics). Think of these as different military strategies: PPIs are the "air strike" against acid factories, protectants are the "reinforced walls," antacids are the "fire extinguishers," and antibiotics are the "special forces" against bacteria:

🚫 Acid Production Inhibitors

Goal: Reduce the amount of acid produced
Classes: PPIs (most potent), H₂ blockers (moderate)
Analogy: Like turning off a faucet at the source rather than mopping up spills
Healing time: Duodenal ulcers: 4 weeks; Gastric ulcers: 6-8 weeks
Maintenance: Often needed for recurrent or complicated ulcers

🛡️ Mucosal Protective Agents

Goal: Strengthen the stomach's natural defenses
Classes: Sucralfate, misoprostol, bismuth
Analogy: Like applying armor to weakened castle walls
Special role: Crucial for NSAID-induced ulcers when NSAIDs can't be stopped
Timing: Often taken separately from other medications to avoid interactions

🧂 Acid Neutralizers

Goal: Chemically neutralize acid already in stomach
Classes: Aluminum, magnesium, calcium, sodium compounds
Analogy: Like pouring baking soda on a chemical spill
Onset: Immediate relief (minutes)
Limitation: Doesn't promote healing, temporary effect only

🦠 H. pylori Eradication

Goal: Eliminate the bacterial infection causing ulcers
Regimens: Triple therapy (PPI + 2 antibiotics) or quadruple therapy
Analogy: Like sending in special forces to eliminate an enemy within
Duration: 10-14 days of treatment
Confirmation: Must test for eradication 4+ weeks after treatment

1. Proton Pump Inhibitors (PPIs)

PPIs are the most potent acid-suppressing drugs available. They work by irreversibly blocking the "proton pump" (H⁺/K⁺ ATPase) in stomach cells. Think of the proton pump as the final switch that turns on acid production—PPIs permanently disable this switch, forcing the body to make new pumps (which takes 24-48 hours):

🔬 Mechanism of Action

Target: H⁺/K⁺ ATPase (proton pump) on the surface of parietal cells
Activation: PPIs are prodrugs activated only in highly acidic environments (like the stomach or inside acid-producing cells)
Irreversible binding: Forms covalent bonds with cysteine residues on the pump → permanent inactivation
Selectivity: Only affects actively secreting pumps (about 70% of total)
Effect: >90% reduction in acid production at steady state (after 3-5 days)
Duration: Effects last 24-48 hours despite short half-life (1-2 hours) due to irreversible binding
Key concept: "Irreversible inhibition" doesn't mean permanent—new pumps are constantly made, but drug effect outlasts its presence in blood

💊 Clinical PPIs Comparison

Omeprazole: Original PPI; CYP2C19 metabolism (genetic variations affect effectiveness); over-the-counter available
Esomeprazole: S-isomer of omeprazole; more consistent metabolism, less CYP2C19 dependency
Pantoprazole: Less CYP2C19 dependent; preferred in patients on multiple medications (fewer interactions)
Lansoprazole: Faster onset than omeprazole; available as orally disintegrating tablets
Rabeprazole: Less dependent on CYP2C19; non-enzymatic metabolism alternative pathway
Dexlansoprazole: Dual delayed release; provides longer acid control
Dosing: Typically once daily 30-60 minutes before first meal (breakfast); twice daily for severe cases
Clinical pearl: Pantoprazole is often preferred in hospitalized patients due to fewer drug interactions

⚠️ PPI Side Effects & Long-Term Risks:

Common: Headache, diarrhea, nausea, abdominal pain
Nutritional:
- Hypomagnesemia (low magnesium) - can cause muscle cramps, arrhythmias
- Vitamin B₁₂ deficiency - interferes with absorption (requires stomach acid)
- Iron and calcium malabsorption - may contribute to osteoporosis risk
Infections:
- Increased risk of C. difficile colitis (3x higher)
- Increased risk of community-acquired pneumonia
Other concerns:
- Acute interstitial nephritis (kidney inflammation)
- Possible increased dementia risk with long-term use (controversial)
- Rebound acid hypersecretion after stopping (taper if used >8 weeks)
Clinical pearl: Use the lowest effective dose for shortest duration; reassess need annually

2. Histamine H₂-Receptor Blockers

H₂ blockers reduce acid production by blocking histamine's action on parietal cells. Think of histamine as one of three keys that unlock acid production (along with gastrin and acetylcholine). H₂ blockers change the lock so the histamine key no longer fits:

🔑 Mechanism of Action

Target: Histamine H₂ receptors on parietal cells
Competitive antagonism: Reversibly blocks histamine binding
Effect: Reduces basal acid secretion by 70%, meal-stimulated secretion by 50%
Specificity: Doesn't block H₁ receptors (so no antihistamine/sedative effects)
Comparison to PPIs: Less potent (70% vs >90% acid reduction), reversible (vs irreversible), faster onset but shorter duration
Key concept: Histamine is the most important acid stimulant; blocking it reduces but doesn't eliminate acid production (gastrin and acetylcholine can still stimulate some acid)

💊 Clinical H₂ Blockers Comparison

Cimetidine (1st generation):
- Antiandrogenic effects: gynecomastia, impotence, reduced libido (at high doses)
- Strong CYP450 inhibitor: many drug interactions (warfarin, phenytoin, theophylline)
- Now rarely used due to side effects and interactions
Ranitidine (2nd generation):
- 10x more potent than cimetidine
- Minimal antiandrogenic effects
- Weak CYP450 inhibitor
- Note: Recalled in many countries due to NDMA (carcinogen) contamination
Famotidine (3rd generation):
- Most potent H₂ blocker (30x more than cimetidine)
- No antiandrogenic effects
- Minimal CYP450 interactions
- Current preferred H₂ blocker
Nizatidine (4th generation):
- Similar to ranitidine
- Minimal CNS penetration (less confusion in elderly)
Dosing: Twice daily for ulcers; once at bedtime for nocturnal acid control
Clinical pearl: Famotidine 20-40 mg at bedtime is excellent for nocturnal acid breakthrough in patients on once-daily PPIs

🔬 Tachyphylaxis Phenomenon:

H₂ blockers often lose effectiveness after 2-4 weeks of continuous use due to "tachyphylaxis" (rapid tolerance). This occurs because:

Histamine receptors upregulate (increase in number) in response to blockade
Other acid-stimulating pathways (gastrin, acetylcholine) become more active
Clinical implication: H₂ blockers work best for short-term use or intermittent dosing; PPIs don't develop tachyphylaxis

3. Mucosal Protective Agents

These agents work by different mechanisms to strengthen the stomach's natural defenses rather than reducing acid. Think of them as "reinforcements for the castle walls" rather than "disarming the attackers":

🩹 Sucralfate (Carafate)

How it works: Reacts with stomach acid to form a thick, sticky paste that adheres to ulcer craters
- Creates a physical barrier against acid, pepsin, and bile
- Selectively binds to damaged/ulcerated tissue (not normal mucosa)
- Stimulates local prostaglandin production and epidermal growth factor
Administration: 1 gram 4 times daily on empty stomach (1 hour before meals and at bedtime)
Duration of coating: 6 hours per dose
Systemic absorption: Minimal (<5%); mostly excreted in feces
Side effects: Constipation (3%), aluminum toxicity in renal failure
Drug interactions: Binds to other drugs in gut → reduce absorption of quinolones, tetracyclines, digoxin, phenytoin (space 2 hours apart)
Clinical use: Stress ulcer prophylaxis in ICU, duodenal ulcers, especially in pregnant women (category B)
Key advantage: No systemic side effects, safe in pregnancy

💊 Misoprostol (Cytotec)

How it works: Synthetic prostaglandin E₁ analog
- Replaces protective prostaglandins depleted by NSAIDs
- Increases mucus and bicarbonate secretion
- Enhances mucosal blood flow
- Directly inhibits acid secretion at high doses
Administration: 200 mcg 4 times daily with food (reduces diarrhea)
Half-life: 30 minutes
Side effects: Diarrhea (30%), abdominal cramps (13%), uterine contractions
Black box warning: ABSOLUTELY CONTRANDICATED IN PREGNANCY (category X) - causes uterine contractions and abortion
Clinical use: Prevention of NSAID-induced ulcers in high-risk patients who must continue NSAIDs
Key advantage: Only agent proven to prevent both gastric and duodenal NSAID ulcers

⚫ Bismuth Subsalicylate (Pepto-Bismol)

How it works: Multiple protective actions
- Coats ulcers and erosions
- Stimulates prostaglandin, mucus, and bicarbonate secretion
- Direct antibacterial effect against H. pylori
- Salicylate component has anti-inflammatory effects
Administration: 524 mg (2 tablets or 30 mL) 4 times daily
Systemic absorption: Bismuth: minimal; salicylate: well absorbed
Side effects: Black tongue and stools (harmless), salicylate toxicity in overdose, tinnitus
Contraindications: Children/teens with viral infections (Reye's syndrome risk), aspirin allergy
Clinical use: Component of H. pylori eradication regimens, symptomatic relief of dyspepsia
Key advantage: Quadruple therapy with bismuth has high eradication rates even with clarithromycin resistance

4. Antacids

Antacids provide rapid, short-term relief by chemically neutralizing stomach acid. Think of them as "chemical sponges" that soak up acid already present in the stomach. They're like putting baking soda on a spill—it helps immediately but doesn't fix the source of the leak:

Antacid	Mechanism	Onset/Duration	Advantages	Disadvantages/Side Effects
Aluminum hydroxide (Amphojel, Alternagel)	Neutralizes HCl → AlCl₃ + H₂O	Slow onset (30 min) Long duration	Constipating (good for patients with diarrhea)	Constipation, binds phosphate (can cause deficiency), aluminum toxicity in renal failure
Magnesium hydroxide (Milk of Magnesia)	Neutralizes HCl → MgCl₂ + H₂O	Fast onset (5-15 min) Medium duration	Laxative effect (good for constipated patients)	Diarrhea, magnesium toxicity in renal failure
Calcium carbonate (Tums, Rolaids)	Neutralizes HCl → CaCl₂ + CO₂ + H₂O	Fast onset (3-5 min) Medium duration	Fastest relief, provides calcium	Rebound acid secretion, constipation, gas/bloating, milk-alkali syndrome with overuse
Sodium bicarbonate (Baking soda)	Neutralizes HCl → NaCl + CO₂ + H₂O	Very fast onset (1-3 min) Short duration	Fastest acting, inexpensive	Systemic absorption → alkalosis, high sodium (bad for heart/kidney patients), rebound acid
Combinations (Maalox, Mylanta, Gelusil)	Aluminum + magnesium	Medium onset Medium duration	Balances constipation/diarrhea	Less severe side effects of each component

🎯 Clinical Tips for Antacid Use:

Timing: Take 1 hour after meals and at bedtime (when acid secretion peaks)
Drug interactions: Separate from other medications by 2-3 hours (binds many drugs)
Duration: Don't use continuously >2 weeks without medical supervision
Symptom pattern: If needing antacids >2x/week, consider evaluation for GERD/PUD
Choice: Match to patient: diarrhea-prone → aluminum; constipated → magnesium; balanced → combination
Avoid in: Renal impairment (aluminum/magnesium toxicity), heart failure (sodium load), osteoporosis (calcium interference)

5. H. pylori Eradication Therapy

H. pylori infection causes most peptic ulcers and eradication prevents recurrence (from 60-80% to <10%). Treatment requires combination therapy because single antibiotics fail (bacteria live in mucus layer and have developed resistance). Think of H. pylori eradication as a "multi-pronged attack": PPIs weaken the bacteria by reducing acid (which they need), antibiotics kill them, and bismuth helps break through their protective biofilm:

🔥 First-Line Regimens (Choose based on local resistance patterns):

🔵 Clarithromycin-Based Triple Therapy
(14 days)

Components:
- PPI (standard dose twice daily)
- Clarithromycin 500 mg twice daily
- Amoxicillin 1 g twice daily OR Metronidazole 500 mg twice daily (if penicillin allergic)
Efficacy: 70-85% (declining due to clarithromycin resistance)
Advantages: Simple, well-tolerated
Disadvantages: High failure with clarithromycin resistance (>15%)
Best for: Areas with <15% clarithromycin resistance, first treatment
Example: Omeprazole 20 mg bid + Clarithromycin 500 mg bid + Amoxicillin 1 g bid

🟡 Bismuth Quadruple Therapy
(10-14 days)

Components:
- PPI (standard dose twice daily)
- Bismuth subsalicylate 524 mg four times daily
- Metronidazole 500 mg three or four times daily
- Tetracycline 500 mg four times daily
Efficacy: 85-90% (even with antibiotic resistance)
Advantages: Effective despite resistance, no clarithromycin
Disadvantages: Complex regimen (14+ pills/day), side effects common
Best for: Penicillin allergy, clarithromycin resistance, failed first therapy
Example: Omeprazole 20 mg bid + Pepto-Bismol 2 tabs qid + Metronidazole 500 mg tid + Tetracycline 500 mg qid

🟢 Alternative & Salvage Therapies

Concomitant Therapy (5 days): PPI + Clarithromycin + Amoxicillin + Metronidazole all twice daily (simpler than sequential)
Sequential Therapy (10 days): Days 1-5: PPI + Amoxicillin; Days 6-10: PPI + Clarithromycin + Tinidazole (theoretical advantage but complex)
Levofloxacin Triple Therapy (10 days): PPI + Levofloxacin + Amoxicillin (for failed first therapy, but quinolone resistance rising)
Rifabutin-Based Therapy: PPI + Rifabutin + Amoxicillin (salvage when multiple failures, expensive)
High-Dose Dual Therapy (14 days): High-dose PPI (e.g., esomeprazole 40 mg tid) + Amoxicillin 750 mg qid (emerging option with good efficacy)

⚠️ Critical Management Points:

Test before treating: Don't treat empirically without confirmation (urea breath test, stool antigen, biopsy)
Confirm eradication: Test 4+ weeks after completing therapy (urea breath test or stool antigen best)
Compliance is key: Explain importance of completing full course despite side effects
Side effect management: Metronidazole: avoid alcohol (disulfiram reaction); Bismuth: harmless black stools
Antibiotic resistance: Increasing problem; know local resistance patterns to choose optimal regimen
PPI continuation: Continue PPI for 4-8 weeks after eradication to ensure ulcer healing

📋 Summary Table: Drugs for Peptic Ulcer Disease

Quick reference guide to PUD medications:

Drug Class	Example(s)	Mechanism of Action	Dosing	Key Indications	Major Side Effects
Proton Pump Inhibitors	Omeprazole, Pantoprazole, Esomeprazole	Irreversibly inhibits H⁺/K⁺ ATPase	20-40 mg once or twice daily before meals	First-line for PUD, GERD, H. pylori, Zollinger-Ellison	Headache, diarrhea, hypomagnesemia, C. difficile risk
H₂ Receptor Antagonists	Famotidine, Nizatidine	Reversibly blocks H₂ receptors	20-40 mg once or twice daily	Mild PUD, nocturnal acid, step-down therapy	Headache, confusion (elderly), tachyphylaxis
Mucosal Protectants	Sucralfate, Misoprostol, Bismuth	Physical barrier, prostaglandin analog, coating+antibacterial	Varies by agent	NSAID ulcers, stress prophylaxis, H. pylori therapy	Constipation, diarrhea, abortion risk (misoprostol)
Antacids	Calcium carbonate, Aluminum/Mg combinations	Chemical neutralization of HCl	As needed after meals/bedtime	Symptomatic relief, adjunct therapy	Constipation (Al), diarrhea (Mg), rebound acid (Ca)
H. pylori Therapy	Triple or quadruple combinations	Antibacterial + acid suppression ± mucosal protection	10-14 day courses	H. pylori-associated ulcers	GI upset, antibiotic resistance, drug interactions

🧠 Key Pharmacologic Principles

Fundamental rules that govern effective PUD management:

Treat the cause: H. pylori ulcers need eradication; NSAID ulcers need drug discontinuation or protection; idiopathic ulcers need acid suppression.
PPIs are first-line for healing: Most potent acid suppressors; fastest healing (4-8 weeks).
Test for H. pylori before treating: "Test and treat" strategy; confirm eradication after therapy.
Address NSAID risk: If NSAIDs must continue, add PPI or misoprostol; consider COX-2 selective NSAIDs.
Consider maintenance therapy: For recurrent ulcers, complications, or elderly patients; lowest effective dose.
Watch for complications: Bleeding, perforation, obstruction require urgent intervention, not just medication.
Lifestyle modifications matter: Smoking cessation, alcohol moderation, stress reduction enhance medical therapy.
Monitor long-term PPI use: Check magnesium, consider bone density, reassess need annually.

⚕️ Patient Education & Counseling Points:

PPI timing: Take 30-60 minutes before breakfast (or first meal) for maximum effect
Complete antibiotic courses: Even if feeling better, finish all H. pylori medications
Avoid NSAIDs: Use acetaminophen instead when possible; if NSAID needed, take with food and protective medication
Recognize alarm symptoms: Vomiting blood, black tarry stools, severe abdominal pain → seek emergency care
Diet modifications: Avoid foods that worsen symptoms (spicy, acidic, fatty foods vary by individual)
Medication spacing: Take antacids and sucralfate 2-3 hours apart from other medications
Don't stop PPIs abruptly: Taper over 2-4 weeks if used >8 weeks to minimize rebound symptoms
Smoking cessation: Smoking delays ulcer healing and increases recurrence

🧭 Conclusion

Peptic ulcer disease management has evolved from a primarily surgical condition to one effectively treated with medications. The therapeutic arsenal now allows us to target the multiple factors contributing to ulcer formation: potent acid suppression with PPIs, mucosal protection with agents like sucralfate and misoprostol, and eradication of H. pylori with combination antibiotic regimens. This multi-pronged approach has dramatically reduced the need for surgery and transformed PUD from a chronic, recurring disease to one that can be effectively cured or controlled.

The choice of therapy must be tailored to the underlying cause: H. pylori-positive ulcers require eradication therapy, NSAID-induced ulcers necessitate discontinuation of the offending drug or addition of protective agents, and idiopathic ulcers respond well to acid suppression alone. Understanding the pharmacology of each drug class—their mechanisms, optimal dosing, side effects, and interactions—is crucial for designing effective treatment regimens and preventing complications.

As we move forward, challenges remain: increasing antibiotic resistance in H. pylori, long-term safety concerns with PPIs, and the ongoing need for cost-effective therapies in resource-limited settings. However, the principles remain clear: identify the cause, select targeted therapy, ensure patient adherence, confirm success when possible, and maintain vigilance for complications. With appropriate pharmacologic management, most peptic ulcers heal completely, and recurrence can be minimized, allowing patients to return to normal health and quality of life.

Peptic ulcer disease represents a breakdown in the stomach's natural defenses — smart pharmacology restores the balance, heals the damage, and prevents recurrence. Remember: we're not just treating symptoms; we're treating the underlying cause, whether it's a bug (H. pylori), a drug (NSAIDs), or excessive acid production.